Cellares CEO on $380M collaboration with Bristol Myers Squibb and its impact
CEO & Founder Conversations
•
6m 18s
Cellares and Bristol Myers Squibb have entered a $380M collaboration to enhance the manufacturing of CAR T cell therapies.
Cellares Co-Founder & CEO Fabian Gerlinghaus talks about the terms of the agreement, its impact and future partnership plans on #NYSEFloorTalk with Judy Khan Shaw.
Up Next in CEO & Founder Conversations
-
Synack CEO on evolution of cyber risk...
Synack’s unique platform of ethical hackers and AI helps organizations identify and rectify security vulnerabilities. Jay Kaplan, CEO and Co-Founder, discusses the evolution of cyber risks with the rise of AI on #NYSEFloorTalk with Judy Shaw. #ai
-
SpectrEco CEO on mission to drive sus...
Faraz Khan, MBE, CEO & Partner of SpectrEco and Founder of Seed Ventures, discusses SpectrEco's mission to drive sustainability in key sectors and the vision propelling the company forward.
#NYSEFloorTalk #sustainability
-
Riskified CEO & Co-Founder Eido Gal e...
Riskified offers an AI-driven platform to help e-commerce businesses manage and mitigate fraud risks.
CEO & Co-Founder Eido Gal joined #NYSEFloorTalk to explore the evolution of e-commerce fraud and Riskified’s solutions to protect and enhance online retail experiences.
